Keeping Track Of IDMP Moves In The EU, US And Beyond
This article was originally published in SRA
Ian Schofield reports on how regulatory agencies are faring with regard to adopting five ISO standards for the identification of medicinal products.
You may also be interested in...
A new action plan from the European Medicines Agency is intended to promote innovation in SMEs by raising awareness of the regulatory tools and support available from the agency, offering more training and education, and promoting collaboration among SMEs, academia, and other stakeholders.
A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.
Mutual recognition of approvals and simplified rules on labeling could help to make COVID-19 vaccines more accessible to populations around the world.